Xtx Topco LTD Iterum Therapeutics PLC Transaction History

Xtx Topco LTD

  • $1.12 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.31 - $0.45 $11,982 - $17,394
-38,654 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$0.39 - $0.74 $604 - $1,147
1,550 Added 4.18%
38,654 $15,000
Q3 2021

Nov 12, 2021
BUY
$0.54 - $2.29 $20,036 - $84,968
37,104 New
37,104 $21,000
Q2 2021

Aug 12, 2021
SELL
$0.97 - $2.39 $12,507 - $30,816
-12,894 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$0.97 - $2.73 $12,507 - $35,200
12,894 New
12,894 $18,000

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $13M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email